AI company Aidoc and the American College of Cardiology (ACC) are collaborating to revolutionise cardiovascular care through industry-leading AI technology. This collaboration will drive enhanced outcomes for patients with incidentally identified coronary artery calcification (CAC) by ensuring that all patients receive the most effective follow-up and ACC guideline-concordant treatment.
Under the collaboration, ACC will review Aidoc’s AI technology to enhance the identification of patients with CAC, a critical precursor to cardiovascular diseases such as heart attack and stroke. Aidoc’s FDA-cleared proprietary technology communicates findings to radiologists and enables coordinated, automatic patient follow-up care.
For example, if a patient presents at the Emergency Department (ED) following a car accident and undergoes a CT scan to check for injuries, Aidoc’s image-based AI will apply all available algorithms based on visible anatomy and identify and document potential CAC directly into the radiology report, even when the scan’s primary purpose is unrelated to cardiovascular concerns. After the confirmed documentation, Aidoc’s ambulatory patient management platform will identify every patient with a mention of CAC and help health systems identify healthy patients with increased risk of cardiovascular disease who are not already under active management.
“Our collaboration with Aidoc is aligned with the ACC’s mission to transform cardiovascular care and improve heart health for all,” said Ami Bhatt, MD, Chief Innovation Officer, American College of Cardiology. “These advanced tools that identify coronary artery calcium and communicate potential increased cardiovascular risk are an important advancement in population health.”